Patents by Inventor Kevin K. Ohrr

Kevin K. Ohrr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Efficient and scalable process for the manufacture of fondaparinux sodium
    Patent number: 8987430
    Abstract: The present invention relates to a process for the synthesis of the Factor Xa anticoagulent Fondaparinux and related compounds. The invention relates, in addition, to efficient and scalable processes for the synthesis of various intermediates useful in the synthesis of Fondaparinux and related compounds.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: March 24, 2015
    Assignee: Reliable Biopharmaceutical Corporation
    Inventors: Payal Parth Patel, Chun Ma, Kevin K. Ohrr, Sourena Nadji
  • EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM
    Publication number: 20130261291
    Abstract: The present invention relates to a process for the synthesis of the Factor Xa anticoagulent Fondaparinux and related compounds. The invention relates, in addition, to efficient and scalable processes for the synthesis of various intermediates useful in the synthesis of Fondaparinux and related compounds.
    Type: Application
    Filed: March 8, 2013
    Publication date: October 3, 2013
    Applicant: Reliable Biopharmaceutical Corporation
    Inventors: Payal Parth PATEL, Chun MA, Kevin K. OHRR, Sourena NADJI
  • Efficient and scalable process for the manufacture of Fondaparinux sodium
    Patent number: 8420790
    Abstract: The present invention relates to a process for the synthesis of the Factor Xa anticoagulent Fondaparinux and related compounds. The invention relates, in addition, to efficient and scalable processes for the synthesis of various intermediates useful in the synthesis of Fondaparinux and related compounds.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: April 16, 2013
    Assignee: Reliable Biopharmaceutical Corporation
    Inventors: Payal Parth Patel, Chun Ma, Kevin K. Ohrr, Sourena Nadji
  • EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM
    Publication number: 20120116066
    Abstract: The present invention relates to a process for the synthesis of the Factor Xa anticoagulent Fondaparinux and related compounds. The invention relates, in addition, to efficient and scalable processes for the synthesis of various intermediates useful in the synthesis of Fondaparinux and related compounds.
    Type: Application
    Filed: October 29, 2010
    Publication date: May 10, 2012
    Applicant: Reliable Biopharmaceutical Corporation
    Inventors: Payal P. Patel, Chun Ma, Kevin K. Ohrr, Sourena Nadji